CES2 immunoreactivity decreased significantly from non-neoplastic “normal” biliary epithelium to high-grade dysplasia (BilIN grade 3) to invasive CCA, but did not differ significantly between CCA subtypes (p = 0.007, p < 0.001 respectively; Fig. 2A,B). The gene discussed is CES2; the disease is cholangiocarcinoma.